Why is Biocon falling/rising?

As of 25-Jul, Biocon Ltd. is currently priced at 394.00, reflecting a decrease of 3.5, or 0.88%. The stock has recently underperformed its sector by 1.05% and has experienced a trend reversal, falling after two consecutive days of gains. Over the past week, Biocon's stock has declined by 1.23%, while it has shown a more favorable performance over the past month with a return of 12.43%. Despite being close to its 52-week high, the stock's delivery volume has fallen significantly, indicating a decrease in investor participation. Positive factors include a high inventory turnover ratio and substantial growth in profit after tax, but the company faces challenges such as a high debt to EBITDA ratio and low long-term growth prospects.
In the broader market context, Biocon's recent performance contrasts with the benchmark Sensex, which has only declined by 0.36% over the past week. While Biocon has generated an 8.93% return over the past year, the Sensex has only returned 1.78% in the same period, suggesting that the stock has been relatively strong over the long term despite its current decline. However, the stock's performance over three years is notably weaker than the benchmark, with a return of 22.19% compared to the Sensex's 46.08%. This disparity highlights the challenges Biocon faces in maintaining investor confidence amidst its financial struggles.